BMY
Bristol-Myers Squibb Co.
Company · XNYS · US · USD
Market price
$61.50
+$6.11 (+11.03%) · 3 months
| Date and time | Price |
|---|---|
| Jun 25, 2026 | $55.39 |
| Jun 26, 2026 | $57.52 |
| Jun 29, 2026 | $58.56 |
| Jun 30, 2026 | $57.62 |
| Jul 1, 2026 | $56.44 |
| Jul 2, 2026 | $58.13 |
| Jul 6, 2026 | $56.70 |
| Jul 7, 2026 | $57.97 |
| Jul 8, 2026 | $57.54 |
| Jul 9, 2026 | $57.94 |
| Jul 10, 2026 | $57.58 |
| Jul 13, 2026 | $59.34 |
| Jul 14, 2026 | $56.95 |
| Jul 15, 2026 | $58.72 |
| Jul 16, 2026 | $60.51 |
| Jul 17, 2026 | $60.74 |
| Jul 20, 2026 | $60.16 |
| Jul 21, 2026 | $60.93 |
| Jul 22, 2026 | $60.76 |
| Jul 23, 2026 | $61.51 |
| Jul 24, 2026 | $62.09 |
| Jul 27, 2026 | $62.56 |
| Jul 28, 2026 | $63.60 |
| Jul 29, 2026 | $63.10 |
| Jul 30, 2026 | $64.86 |
| Jul 31, 2026 | $65.31 |
| Aug 3, 2026 | $65.47 |
| Aug 4, 2026 | $65.89 |
| Aug 5, 2026 | $63.63 |
| Aug 6, 2026 | $64.15 |
| Aug 7, 2026 | $64.72 |
| Aug 10, 2026 | $64.84 |
| Aug 11, 2026 | $63.61 |
| Aug 12, 2026 | $63.70 |
| Aug 13, 2026 | $64.65 |
| Aug 14, 2026 | $63.83 |
| Aug 17, 2026 | $64.63 |
| Aug 18, 2026 | $66.05 |
| Aug 19, 2026 | $67.61 |
| Aug 20, 2026 | $65.47 |
| Aug 21, 2026 | $67.01 |
| Aug 24, 2026 | $67.28 |
| Aug 25, 2026 | $67.92 |
| Aug 26, 2026 | $67.57 |
| Aug 27, 2026 | $66.95 |
| Aug 28, 2026 | $66.58 |
| Aug 31, 2026 | $66.81 |
| Sep 1, 2026 | $66.92 |
| Sep 2, 2026 | $67.66 |
| Sep 3, 2026 | $68.09 |
| Sep 4, 2026 | $66.82 |
| Sep 8, 2026 | $64.69 |
| Sep 9, 2026 | $64.41 |
| Sep 10, 2026 | $63.75 |
| Sep 11, 2026 | $63.64 |
| Sep 14, 2026 | $64.10 |
| Sep 15, 2026 | $63.73 |
| Sep 16, 2026 | $63.60 |
| Sep 17, 2026 | $62.84 |
| Sep 18, 2026 | $63.06 |
| Sep 21, 2026 | $62.62 |
| Sep 22, 2026 | $62.25 |
| Sep 23, 2026 | $61.15 |
| Sep 24, 2026 | $61.50 |
- Period change
- +11.03%
- Period low
- $55.39
- Period high
- $68.09
- Observations
- 64
- Updated
- Sep 24, 2026, 8:00 PM
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Company websiteClassifications
- Biotechnology · Biotech
- Pharmaceuticals · Pharma
- Healthcare
Market details
- Type
- Company
- Market
- XNYS
- Operating market
- XNYS
- Country
- US
- Currency
- USD
- Market capitalization
- $127,914,791,758.72
- Employees
- 32.5K